Aromatase Expression in Stromal Cells of Endometrioid Endometrial Cancer Correlates with Poor Survival
Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between aromatase expressi...
Saved in:
| Published in | Clinical cancer research Vol. 11; no. 6; pp. 2188 - 2194 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Philadelphia, PA
American Association for Cancer Research
15.03.2005
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients
with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between
aromatase expression and clinicopathologic parameters were analyzed.
Results: Immunohistochemical staining for aromatase was positive for 32 (58%), 20 (36%), and 19 (34%) patients in cancer epithelial
cells, stromal cells, and myometrial cells around the flank invasion, respectively. In situ hybridization also detected aromatase mRNA in all three types of cells. RT-PCR analysis revealed that aromatase mRNA was
2.5 ± 1.0 amol/μg total RNA (mean ± SE; n = 7) in tumor tissue. Western blot analysis detected the expected aromatase protein size of 58 kDa in cancer tissues more
abundantly than in cancer-free endometrium ( n = 3). The immunoreactivity in stromal cells correlated positively with advanced surgical stage and poor survival. Survival
analysis revealed that the immunoreactivity of stromal cells was a significant prognostic factor, independent of histologic
grade, muscular invasion, and lymph node metastasis, but dependent on surgical stage. By contrast, the immunoreactivity of
aromatase both in cancer epithelial cells and myometrial cells did not correlate with prognosis.
Conclusions: To the best of our knowledge, this is the first evidence associating intratumoral aromatase expression in stromal cells and
poor survival in endometrioid endometrial cancer. This positive linkage indicates that local expression of aromatase plays
a role in tumor progression through the formation of in situ estrogens. In situ expression of aromatase may offer a potential target for management of endometrial cancers. |
|---|---|
| AbstractList | Abstract
Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between aromatase expression and clinicopathologic parameters were analyzed.
Results: Immunohistochemical staining for aromatase was positive for 32 (58%), 20 (36%), and 19 (34%) patients in cancer epithelial cells, stromal cells, and myometrial cells around the flank invasion, respectively. In situ hybridization also detected aromatase mRNA in all three types of cells. RT-PCR analysis revealed that aromatase mRNA was 2.5 ± 1.0 amol/μg total RNA (mean ± SE; n = 7) in tumor tissue. Western blot analysis detected the expected aromatase protein size of 58 kDa in cancer tissues more abundantly than in cancer-free endometrium (n = 3). The immunoreactivity in stromal cells correlated positively with advanced surgical stage and poor survival. Survival analysis revealed that the immunoreactivity of stromal cells was a significant prognostic factor, independent of histologic grade, muscular invasion, and lymph node metastasis, but dependent on surgical stage. By contrast, the immunoreactivity of aromatase both in cancer epithelial cells and myometrial cells did not correlate with prognosis.
Conclusions: To the best of our knowledge, this is the first evidence associating intratumoral aromatase expression in stromal cells and poor survival in endometrioid endometrial cancer. This positive linkage indicates that local expression of aromatase plays a role in tumor progression through the formation of in situ estrogens. In situ expression of aromatase may offer a potential target for management of endometrial cancers. PURPOSE AND EXPERIMENTAL DESIGNTo assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between aromatase expression and clinicopathologic parameters were analyzed.RESULTSImmunohistochemical staining for aromatase was positive for 32 (58%), 20 (36%), and 19 (34%) patients in cancer epithelial cells, stromal cells, and myometrial cells around the flank invasion, respectively. In situ hybridization also detected aromatase mRNA in all three types of cells. RT-PCR analysis revealed that aromatase mRNA was 2.5 +/- 1.0 amol/mug total RNA (mean +/- SE; n = 7) in tumor tissue. Western blot analysis detected the expected aromatase protein size of 58 kDa in cancer tissues more abundantly than in cancer-free endometrium (n = 3). The immunoreactivity in stromal cells correlated positively with advanced surgical stage and poor survival. Survival analysis revealed that the immunoreactivity of stromal cells was a significant prognostic factor, independent of histologic grade, muscular invasion, and lymph node metastasis, but dependent on surgical stage. By contrast, the immunoreactivity of aromatase both in cancer epithelial cells and myometrial cells did not correlate with prognosis.CONCLUSIONSTo the best of our knowledge, this is the first evidence associating intratumoral aromatase expression in stromal cells and poor survival in endometrioid endometrial cancer. This positive linkage indicates that local expression of aromatase plays a role in tumor progression through the formation of in situ estrogens. In situ expression of aromatase may offer a potential target for management of endometrial cancers. Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between aromatase expression and clinicopathologic parameters were analyzed. Results: Immunohistochemical staining for aromatase was positive for 32 (58%), 20 (36%), and 19 (34%) patients in cancer epithelial cells, stromal cells, and myometrial cells around the flank invasion, respectively. In situ hybridization also detected aromatase mRNA in all three types of cells. RT-PCR analysis revealed that aromatase mRNA was 2.5 ± 1.0 amol/μg total RNA (mean ± SE; n = 7) in tumor tissue. Western blot analysis detected the expected aromatase protein size of 58 kDa in cancer tissues more abundantly than in cancer-free endometrium ( n = 3). The immunoreactivity in stromal cells correlated positively with advanced surgical stage and poor survival. Survival analysis revealed that the immunoreactivity of stromal cells was a significant prognostic factor, independent of histologic grade, muscular invasion, and lymph node metastasis, but dependent on surgical stage. By contrast, the immunoreactivity of aromatase both in cancer epithelial cells and myometrial cells did not correlate with prognosis. Conclusions: To the best of our knowledge, this is the first evidence associating intratumoral aromatase expression in stromal cells and poor survival in endometrioid endometrial cancer. This positive linkage indicates that local expression of aromatase plays a role in tumor progression through the formation of in situ estrogens. In situ expression of aromatase may offer a potential target for management of endometrial cancers. To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were evaluated for expression of aromatase using immunohistochemistry, and the correlation between aromatase expression and clinicopathologic parameters were analyzed. Immunohistochemical staining for aromatase was positive for 32 (58%), 20 (36%), and 19 (34%) patients in cancer epithelial cells, stromal cells, and myometrial cells around the flank invasion, respectively. In situ hybridization also detected aromatase mRNA in all three types of cells. RT-PCR analysis revealed that aromatase mRNA was 2.5 +/- 1.0 amol/mug total RNA (mean +/- SE; n = 7) in tumor tissue. Western blot analysis detected the expected aromatase protein size of 58 kDa in cancer tissues more abundantly than in cancer-free endometrium (n = 3). The immunoreactivity in stromal cells correlated positively with advanced surgical stage and poor survival. Survival analysis revealed that the immunoreactivity of stromal cells was a significant prognostic factor, independent of histologic grade, muscular invasion, and lymph node metastasis, but dependent on surgical stage. By contrast, the immunoreactivity of aromatase both in cancer epithelial cells and myometrial cells did not correlate with prognosis. To the best of our knowledge, this is the first evidence associating intratumoral aromatase expression in stromal cells and poor survival in endometrioid endometrial cancer. This positive linkage indicates that local expression of aromatase plays a role in tumor progression through the formation of in situ estrogens. In situ expression of aromatase may offer a potential target for management of endometrial cancers. |
| Author | Tomoya Segawa Tadayuki Kasai Kazunori Shinohara Makio Shozu Kouich Murakami Satoshi Ohno Kazuhito Nomura Masaki Inoue |
| Author_xml | – sequence: 1 givenname: Tomoya surname: SEGAWA fullname: SEGAWA, Tomoya organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 2 givenname: Makio surname: SHOZU fullname: SHOZU, Makio organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 3 givenname: Kouich surname: MURAKAMI fullname: MURAKAMI, Kouich organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 4 givenname: Tadayuki surname: KASAI fullname: KASAI, Tadayuki organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 5 givenname: Kazunori surname: SHINOHARA fullname: SHINOHARA, Kazunori organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 6 givenname: Kazuhito surname: NOMURA fullname: NOMURA, Kazuhito organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 7 givenname: Satoshi surname: OHNO fullname: OHNO, Satoshi organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan – sequence: 8 givenname: Masaki surname: INOUE fullname: INOUE, Masaki organization: Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16626003$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15788666$$D View this record in MEDLINE/PubMed |
| BookMark | eNpFkctuGyEYRlGVqInTPkIrNo2yGRfMdZbRyLlIkRol7Rox-KemmhlcGMfN24epHXnFhzgfl8MMnQxxAIS-UDKnVOjvlChdEc4W86Z5KqGiWtQf0DkVQlVsIcVJye_MGZrl_IcQyinhH9EZFUprKeU58tcp9na0GfDy3yZBziEOOAz4eZwWOtxA12UcPV4Oq9jDmEIMq-NkIuzgIOEmpgSdHSHjXRjX-DHGhJ-36SW82O4TOvW2y_D5MF6gXzfLn81d9fDj9r65fqgcU2Ssaqa1kNpyRbwlzjLNfc3bthZOgpI1aFYr5zStrVBcWL_yrarblquWc68cu0CX-303Kf7dQh5NH7IrT7ADxG02UgleiqSAYg-6FHNO4M0mhd6mV0OJmQSbSZ6Z5JkiuAQzCS69r4cDtm0Pq2PrYLQA3w6Azc52PhU7IR85KReSEFa4qz23Dr_Xu5DAuP8eyxeATW5dLmGkWVCt2RsGUpSg |
| CitedBy_id | crossref_primary_10_1111_jog_13743 crossref_primary_10_1016_j_canlet_2008_10_008 crossref_primary_10_1111_j_1365_2559_2007_02612_x crossref_primary_10_1002_ijc_28679 crossref_primary_10_1007_s10517_006_0397_4 crossref_primary_10_3390_cancers13092149 crossref_primary_10_1016_j_ygyno_2013_09_023 crossref_primary_10_1007_s11010_021_04099_0 crossref_primary_10_1517_13543784_2011_566862 crossref_primary_10_1002_path_5004 crossref_primary_10_1177_2470289718801379 crossref_primary_10_3390_ijms19103276 crossref_primary_10_1186_s13048_023_01201_6 crossref_primary_10_1093_molehr_gaad017 crossref_primary_10_1016_j_mce_2013_07_026 crossref_primary_10_2478_v10039_012_0055_1 crossref_primary_10_1016_j_mce_2018_10_004 crossref_primary_10_1016_j_mce_2010_11_023 crossref_primary_10_1111_j_1440_1789_2009_01047_x crossref_primary_10_1186_1477_7827_7_102 crossref_primary_10_3389_fphar_2017_00368 crossref_primary_10_1507_endocrj_KR_114 crossref_primary_10_3390_biom12111624 crossref_primary_10_1007_s00129_006_1864_8 crossref_primary_10_1515_HMBCI_2010_027 crossref_primary_10_3390_ijms19020611 crossref_primary_10_1530_ERC_15_0470 crossref_primary_10_1016_j_ygyno_2018_10_024 crossref_primary_10_1016_j_mce_2005_10_013 crossref_primary_10_3389_fendo_2023_1156680 crossref_primary_10_1016_j_steroids_2007_09_003 crossref_primary_10_1002_med_20131 crossref_primary_10_1016_j_bbalip_2019_08_008 crossref_primary_10_1111_IGC_0b013e3181a47c25 crossref_primary_10_1007_s13277_013_0991_9 crossref_primary_10_1080_15384047_2017_1414762 crossref_primary_10_1158_0008_5472_CAN_09_4653 crossref_primary_10_1196_annals_1397_010 crossref_primary_10_3389_fphar_2018_00940 crossref_primary_10_1016_j_fertnstert_2005_12_057 |
| Cites_doi | 10.1006/gyno.2000.5865 10.1016/0022-4731(86)90362-6 10.1210/jcem.79.6.7989490 10.1177/1071557601008001S21 10.1210/jcem.87.8.8733 10.1023/A:1020531329686 10.1016/0960-0760(93)90251-Q 10.1016/S0378-5122(98)00034-6 10.1016/S0301-2115(02)00147-1 10.1517/13543784.12.3.337 10.1023/A:1006029612990 10.1210/jc.83.4.1319 10.1016/0022-4731(90)90167-Q 10.1111/j.1349-7006.1994.tb02365.x 10.1210/jc.86.7.3436 10.1007/s00432-003-0427-9 10.1677/erc.0.0060197 10.1023/A:1006009128920 10.1097/00042192-199805040-00004 10.1016/S0378-5122(02)00140-8 10.1023/A:1006033813899 10.1210/endo.141.10.7719 10.1210/jcem-62-3-508 10.1093/jnci/88.16.1127 10.1016/0378-5122(86)90008-3 10.1046/j.1471-0528.2003.02389.x 10.1016/S1359-6349(04)90893-2 10.1016/S0960-0760(03)00363-7 10.1210/jcem-55-5-1029 10.1016/0022-4731(89)90408-1 10.1016/0046-8177(94)90127-9 |
| ContentType | Journal Article |
| Copyright | 2005 INIST-CNRS |
| Copyright_xml | – notice: 2005 INIST-CNRS |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1158/1078-0432.CCR-04-1859 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1557-3265 |
| EndPage | 2194 |
| ExternalDocumentID | 10_1158_1078_0432_CCR_04_1859 15788666 16626003 11_6_2188 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | - 08R 29B 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS AAPBV ABFLS ABOCM ACIWK ACPRK ADACO ADBBV ADBIT AENEX AETEA AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DU5 E3Z EBS EJD F5P FH7 FRP GJ GX1 H13 H~9 IH2 KQ8 L7B LSO MVM O0- OHT OK1 P0W P2P RCR RHF RHI RNS SJN UDS VH1 W2D WOQ X7M XFK XJT ZA5 ZCG ZGI --- .55 .GJ 18M 1CY 2FS 476 4H- 6J9 ACGFO ADCOW ADGIM ADNWM AFHIN AFOSN AI. BR6 BTFSW IQODW J5H QTD TR2 W8F WHG YKV ACSVP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c370t-9388568a470fa0ca384f94bb95c6e769e8397cc819a5745afdfb79bb47b44f7c3 |
| ISSN | 1078-0432 |
| IngestDate | Fri Aug 16 22:39:03 EDT 2024 Fri Aug 23 02:13:00 EDT 2024 Sun Jul 28 06:58:00 EDT 2024 Fri Nov 25 01:06:22 EST 2022 Fri Jan 15 20:33:59 EST 2021 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Endometrium cancer Enzyme Uterine diseases Stromal cell Estrogen synthase Malignant tumor Gene expression Survival Female genital diseases |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c370t-9388568a470fa0ca384f94bb95c6e769e8397cc819a5745afdfb79bb47b44f7c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 15788666 |
| PQID | 67547450 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_67547450 crossref_primary_10_1158_1078_0432_CCR_04_1859 pubmed_primary_15788666 pascalfrancis_primary_16626003 highwire_cancerresearch_11_6_2188 |
| ProviderPackageCode | RHF RHI |
| PublicationCentury | 2000 |
| PublicationDate | 2005-03-15 |
| PublicationDateYYYYMMDD | 2005-03-15 |
| PublicationDate_xml | – month: 03 year: 2005 text: 2005-03-15 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | Philadelphia, PA |
| PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
| PublicationTitle | Clinical cancer research |
| PublicationTitleAlternate | Clin Cancer Res |
| PublicationYear | 2005 |
| Publisher | American Association for Cancer Research |
| Publisher_xml | – name: American Association for Cancer Research |
| References | 2022061104233027300_B19 2022061104233027300_B18 2022061104233027300_B17 2022061104233027300_B16 2022061104233027300_B11 2022061104233027300_B33 2022061104233027300_B10 2022061104233027300_B32 2022061104233027300_B31 2022061104233027300_B30 2022061104233027300_B15 2022061104233027300_B14 2022061104233027300_B13 2022061104233027300_B35 2022061104233027300_B12 2022061104233027300_B34 2022061104233027300_B4 2022061104233027300_B3 2022061104233027300_B6 2022061104233027300_B5 2022061104233027300_B8 2022061104233027300_B7 2022061104233027300_B9 2022061104233027300_B29 2022061104233027300_B28 2022061104233027300_B27 2022061104233027300_B2 2022061104233027300_B1 2022061104233027300_B22 2022061104233027300_B21 2022061104233027300_B20 2022061104233027300_B26 2022061104233027300_B25 2022061104233027300_B24 2022061104233027300_B23 |
| References_xml | – ident: 2022061104233027300_B35 doi: 10.1006/gyno.2000.5865 – ident: 2022061104233027300_B5 doi: 10.1016/0022-4731(86)90362-6 – ident: 2022061104233027300_B9 doi: 10.1210/jcem.79.6.7989490 – ident: 2022061104233027300_B25 doi: 10.1177/1071557601008001S21 – ident: 2022061104233027300_B15 doi: 10.1210/jcem.87.8.8733 – ident: 2022061104233027300_B17 doi: 10.1023/A:1020531329686 – ident: 2022061104233027300_B8 doi: 10.1016/0960-0760(93)90251-Q – ident: 2022061104233027300_B24 doi: 10.1016/S0378-5122(98)00034-6 – ident: 2022061104233027300_B19 – ident: 2022061104233027300_B31 doi: 10.1016/S0301-2115(02)00147-1 – ident: 2022061104233027300_B16 doi: 10.1517/13543784.12.3.337 – ident: 2022061104233027300_B12 doi: 10.1023/A:1006029612990 – ident: 2022061104233027300_B4 – ident: 2022061104233027300_B2 – ident: 2022061104233027300_B22 doi: 10.1210/jc.83.4.1319 – ident: 2022061104233027300_B33 doi: 10.1016/0022-4731(90)90167-Q – ident: 2022061104233027300_B1 doi: 10.1111/j.1349-7006.1994.tb02365.x – ident: 2022061104233027300_B23 doi: 10.1210/jc.86.7.3436 – ident: 2022061104233027300_B7 doi: 10.1007/s00432-003-0427-9 – ident: 2022061104233027300_B10 – ident: 2022061104233027300_B32 doi: 10.1677/erc.0.0060197 – ident: 2022061104233027300_B11 doi: 10.1023/A:1006009128920 – ident: 2022061104233027300_B29 doi: 10.1097/00042192-199805040-00004 – ident: 2022061104233027300_B27 doi: 10.1016/S0378-5122(02)00140-8 – ident: 2022061104233027300_B13 doi: 10.1023/A:1006033813899 – ident: 2022061104233027300_B14 doi: 10.1210/endo.141.10.7719 – ident: 2022061104233027300_B26 doi: 10.1210/jcem-62-3-508 – ident: 2022061104233027300_B3 doi: 10.1093/jnci/88.16.1127 – ident: 2022061104233027300_B28 doi: 10.1016/0378-5122(86)90008-3 – ident: 2022061104233027300_B30 doi: 10.1046/j.1471-0528.2003.02389.x – ident: 2022061104233027300_B34 doi: 10.1016/S1359-6349(04)90893-2 – ident: 2022061104233027300_B20 doi: 10.1016/S0960-0760(03)00363-7 – ident: 2022061104233027300_B21 doi: 10.1210/jcem-55-5-1029 – ident: 2022061104233027300_B6 doi: 10.1016/0022-4731(89)90408-1 – ident: 2022061104233027300_B18 doi: 10.1016/0046-8177(94)90127-9 |
| SSID | ssj0014104 |
| Score | 2.0677881 |
| Snippet | Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients... To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients with endometrial cancer were... Abstract Purpose and Experimental Design: To assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55... PURPOSE AND EXPERIMENTAL DESIGNTo assess the prognostic significance of intratumoral aromatase in endometrioid endometrial cancer, sections from 55 patients... |
| SourceID | proquest crossref pubmed pascalfrancis highwire |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 2188 |
| SubjectTerms | Antineoplastic agents Aromatase - genetics Aromatase - metabolism Biological and medical sciences Carcinoma, Endometrioid - diagnosis Carcinoma, Endometrioid - enzymology Disease Progression Endometrium - enzymology Epithelial Cells - enzymology Epithelial Cells - pathology Estrogen formation Female Female genital diseases Gynecology. Andrology. Obstetrics Humans hybridization immunohistochemistry in situ In Situ Hybridization Lymphatic Metastasis - pathology Medical sciences Middle Aged Myometrium - enzymology Myometrium - pathology Neoplasm Invasiveness - pathology Pharmacology. Drug treatments Prognosis prognostic indicators Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics RNA, Messenger - metabolism Stromal Cells - enzymology survival analysis Survival Rate Tumors |
| Title | Aromatase Expression in Stromal Cells of Endometrioid Endometrial Cancer Correlates with Poor Survival |
| URI | http://clincancerres.aacrjournals.org/content/11/6/2188.abstract https://www.ncbi.nlm.nih.gov/pubmed/15788666 https://search.proquest.com/docview/67547450 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6FIiFeEDfhKIvEW5Rgx7tr-7EKRYUqCLWp1Ddrvd5trTbeKgeo_X38MGYPH4EgFV4sx_Ex9vd5dnY8B0LvlRqnuYkLC5VKYILC6DCNYc5DJAx3ShYitK0Tpl_ZwQn5ckpPe72fnail9SofiZuteSX_gypsA1xNluw_INucFDbAOuALS0AYlrfCeG-hweCEcchULHYBrTZw8Xhl_rgcTOSlK468XxV6bnpn6bJof5g9DOgL0AoLm9QifbLbN60XoFNAjXz3MtTFDOpESuEO9LWCGp_yTM_1NQcNdMZ_NAp_ClaqHhyf65t1o9_1uhTnA4CZX_B52foPCn69vigHh3zJyw2PBDUhWS4ns5MEANqpQzAbM-lv6agrmdO6gSnzS7yjU3pNTEH7jV0jiUZVhx1Kbupd1xzwzwGBJtY34S8wmkyOzLcgsFLS7v6A69XcsiQEFZYwtqU892_DZhPMCDMolhkB7qC74zilxgXw8fNh8y2LhLaJZSODzyMDyT5slct2inJCbBpLdQFrE7_Ll4C1cr1X_j45skbS7CF64Gc3eM9R9RHqyeoxujf18RtPkGoYi1vG4rLCnrHYMhZrhbuMxR3GYgcvbhmLDWOxYSyuGfsUnXzan00Ohr7Tx1BEcbAaplGSUJZwEgeKB4JHCVEpyfOUCiZjlkow42MhwHrlNCaUq0LlcZrnJM4JUbGInqGdSlfyBcIJZ5EKGRNJERKaqyTksggiGQW5AHM07qNR_UizK1fQJbMTYZpkBo7MwJEBHLCSGTj66F394DP3btWvVtYg30e7G4i0Z2bGYRBEffS2higD_W0-yvFK6vUygwk7gVsK-ui5Q6491pPg5S0EeIXuuzfR-AZfo53VYi3fgLW8ynctGX8BUjXAkg |
| link.rule.ids | 315,786,790,27957,27958 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aromatase+Expression+in+Stromal+Cells+of+Endometrioid+Endometrial+Cancer+Correlates+with+Poor+Survival&rft.jtitle=Clinical+cancer+research&rft.au=Tomoya+Segawa&rft.au=Makio+Shozu&rft.au=Kouich+Murakami&rft.au=Tadayuki+Kasai&rft.date=2005-03-15&rft.pub=American+Association+for+Cancer+Research&rft.issn=1078-0432&rft.eissn=1557-3265&rft.volume=11&rft.issue=6&rft.spage=2188&rft_id=info:doi/10.1158%2F1078-0432.CCR-04-1859&rft_id=info%3Apmid%2F15788666&rft.externalDBID=n%2Fa&rft.externalDocID=11_6_2188 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon |